From: Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Cardiomyopathy (N = 115, 19.5%) | No Cardiomyopathy (N = 474, 80.5%) | P-value | |
---|---|---|---|
Sex | |||
Male | 73 (63.5) | 249 (52.5) | 0.03 |
Female | 42 (36.5) | 225 (47.5) | |
Age at First Dose (years) | 10.8 (4.9–15.1) | 7.1 (3.4–12.9) | < 0.001 |
Race | |||
White | 57 (50.4) | 244 (51.6) | 0.03 |
Hispanic | 32 (28.3) | 160 (33.8) | |
Black | 18 (15.9) | 34 (7.2) | |
Other (including Asian) | 6 (5.3) | 35 (7.4) | |
Unknown | 2 (1.7) | 1 (0.2) | |
Body Surface Area (m2) | 1.20 (0.74–1.66) | 0.88 (0.62–1.42) | < 0.001 |
Diagnosis | |||
Leukemia | 57 (49.6) | 253 (53.4) | 0.08 |
Solid Tumors | 36 (31.3) | 126 (26.6) | |
Lymphoma | 17 (14.8) | 82 (17.3) | |
Brain Tumors | 1 (0.9) | 10 (2.1) | |
Multiple Diagnoses | 4 (3.5) | 3 (0.6) | |
Anthracycline Dose Total (mg/m2) | 236.0 (153.0–329.0) | 164.5 (92.0–232.0) | < 0.001 |
Cardiotoxic Radiation | |||
Yes | 42 (36.5) | 152 (32.1) | 0.36 |
No | 73 (63.5) | 322 (55.7) | |
Vital Status | |||
Alive | 76 (66.1) | 417 (88.0) | < 0.001 |
Died | 39 (33.9) | 57 (12.0) |